WallStreetZenWallStreetZen

NASDAQ: BTAI
Bioxcel Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Bioxcel Therapeutics earnings were -$75.3M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest BTAI earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$12.7M, up 1.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BTAI reported annual earnings of -$69.9M, with 17.3% growth. The next BTAI earnings date is Aug 11, 2026.

BTAI earnings history

Current Revenue
$680.0k
Current Earnings
-$75.3M
Current Profit Margin
-11,078.5%

BTAI Return on Equity

Current Company
N/A
Current Industry
-141.9%
Current Market
13.5%

BTAI Return on Assets

Current Company
-201.5%
Current Industry
-13.7%
BTAI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BTAI announces earnings.

BTAI Return on Capital Employed

Current Company
277.29%
Current Industry
-9.6%
BTAI has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BTAI vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
BTAI-$57.86M-$75.33MN/A-$4.52
QCLS-$11.75M-$14.57MN/A-$14.58
TVRD-$15.23M-$15.44MN/A-$1.65
VYNE-$21.43M-$21.46MN/A-$0.49
ATNM-$22.64M-$23.47MN/A-$0.75
View Top Biotech Stocks

BTAI earnings dates

Next earnings date
Aug 11, 2026

Bioxcel Therapeutics Earnings Reports & History FAQ

What were Bioxcel Therapeutics's earnings last quarter?

Bioxcel Therapeutics (NASDAQ: BTAI) reported Q1 2026 earnings per share (EPS) of -$0.54, up 64% year over year. Total BTAI earnings for the quarter were -$12.69 million. In the same quarter last year, Bioxcel Therapeutics's earnings per share (EPS) was -$1.50.

If you're new to stock investing, here's how to buy Bioxcel Therapeutics stock.

When does Bioxcel Therapeutics report earnings?

The next BTAI earnings call is Aug 11, 2026. Add BTAI to your watchlist to be reminded of Bioxcel Therapeutics's next earnings date.

Is Bioxcel Therapeutics profitable or losing money?

As of the last Bioxcel Therapeutics earnings report, Bioxcel Therapeutics is currently losing money. Bioxcel Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$75.33 million, a 88.04% increase year over year.

What was BTAI's earnings growth in the past year?

As of Bioxcel Therapeutics's earnings date in Q3 2026, Bioxcel Therapeutics's earnings has grown year over year. BTAI earnings in the past year totalled -$75.33 million.

What are Bioxcel Therapeutics's earnings expectations?

The current EPS estimate for Bioxcel Therapeutics's earnings report in Aug 11, 2026 is -$0.50.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.